Avestar Capital, LLC Nuvasive Inc Transaction History

Avestar Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$48.09 - $57.79 $230,447 - $276,929	-4,792 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$47.19 - $62.68 $45,160 - $59,984	957 Added 24.95%	4,792 $251,000
Q3 2021 Nov 09, 2021	BUY	$56.91 - $67.81 $36,706 - $43,737	645 Added 20.22%	3,835 $230,000
Q2 2021 Aug 03, 2021	BUY	$64.02 - $71.72 $204,223 - $228,786	3,190 New	3,190 $216,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.